Profile
Bridgepoint is a private equity firm headquartered in London, United Kingdom, founded in 1984. The firm has a team of over 214 professionals and is known for its expertise in private equity, infrastructure, and private credit investments. Bridgepoint differentiates itself with a strong local presence in Europe, North America, and Asia, combining global scale with local market and sector expertise.
Bridgepoint invests in sectors such as advanced industrials, business services, financial services, consumer, healthcare, and technology. The firm typically engages in buyout and growth/expansion investments, with a focus on late-stage opportunities. Bridgepoint manages assets worth €67 billion, with notable funds including Bridgepoint Europe IV and V, and Bridgepoint Development Capital III.
Notable investments by Bridgepoint include Obagi Cosmeceuticals - personal products, Neosalus Solutions - decision/risk analysis, Helio Intelligence - business/productivity software, Team Life - other healthcare services, and Elgin White - IT consulting and outsourcing.
Industry
Bridgepoint Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Bridgepoint Europe IV
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Services (B2C)
Financial Services
Fintech
Healthcare Services
Energy
CleanTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$1000 M
|
December 2008
|
|
Bridgepoint Europe V
|
Private Equity (PE)
|
Business Services (B2B)
Financial Services
Healthcare Services
Energy
CleanTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$2600 M
|
June 2015
|
|
Bridgepoint Development Capital III
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Services (B2C)
Digital
Education
Healthcare Services
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$880 M
|
August 2016
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.